United States Alzheimer's Disease Drug Market Report 2016

November 2016 | 98 pages | ID: U6A3C431D85EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Alzheimer's Disease Drug

Revenue, means the sales value of Alzheimer's Disease Drug

Revenue, means the salies sales (consumption) of Alzheimer's Disease Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Eisai
• Pfizer
• Novartis
• Shire
• Janssen
• Forest Laboratories
• H. Lundbeck
• Merz
• Daiichi Sankyo

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Centrally acting AChE inhibintors
• NMDA antagonists
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Alzheimer's Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Alzheimer's Disease Drug Market Report 2016

1 ALZHEIMER'S DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Alzheimer's Disease Drug
1.2 Classification of Alzheimer's Disease Drug
  1.2.1 Centrally acting AChE inhibintors
  1.2.2 NMDA antagonists
  1.2.3 Type III
1.3 Application of Alzheimer's Disease Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Alzheimer's Disease Drug (2011-2021)
  1.4.1 United States Alzheimer's Disease Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Alzheimer's Disease Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES ALZHEIMER'S DISEASE DRUG COMPETITION BY MANUFACTURERS

2.1 United States Alzheimer's Disease Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Alzheimer's Disease Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Alzheimer's Disease Drug Average Price by Manufactures (2015 and 2016)
2.4 Alzheimer's Disease Drug Market Competitive Situation and Trends
  2.4.1 Alzheimer's Disease Drug Market Concentration Rate
  2.4.2 Alzheimer's Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ALZHEIMER'S DISEASE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Alzheimer's Disease Drug Sales and Market Share by Type (2011-2016)
3.2 United States Alzheimer's Disease Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Alzheimer's Disease Drug Price by Type (2011-2016)
3.4 United States Alzheimer's Disease Drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ALZHEIMER'S DISEASE DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Alzheimer's Disease Drug Sales and Market Share by Application (2011-2016)
4.2 United States Alzheimer's Disease Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ALZHEIMER'S DISEASE DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Eisai
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Pfizer
  5.2.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Novartis
  5.3.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Shire
  5.4.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Shire Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Janssen
  5.5.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Janssen Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Forest Laboratories
  5.6.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Forest Laboratories Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 H. Lundbeck
  5.7.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 H. Lundbeck Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Merz
  5.8.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Merz Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Daiichi Sankyo
  5.9.2 Alzheimer's Disease Drug Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 ALZHEIMER'S DISEASE DRUG MANUFACTURING COST ANALYSIS

6.1 Alzheimer's Disease Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Alzheimer's Disease Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Alzheimer's Disease Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Alzheimer's Disease Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ALZHEIMER'S DISEASE DRUG MARKET FORECAST (2016-2021)

10.1 United States Alzheimer's Disease Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Alzheimer's Disease Drug Sales Forecast by Type (2016-2021)
10.3 United States Alzheimer's Disease Drug Sales Forecast by Application (2016-2021)
10.4 Alzheimer's Disease Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Alzheimer's Disease Drug
Table Classification of Alzheimer's Disease Drug
Figure United States Sales Market Share of Alzheimer's Disease Drug by Type in 2015
Figure Centrally acting AChE inhibintors Picture
Figure NMDA antagonists Picture
Table Application of Alzheimer's Disease Drug
Figure United States Sales Market Share of Alzheimer's Disease Drug by Application in 2015
Figure United States Alzheimer's Disease Drug Sales and Growth Rate (2011-2021)
Figure United States Alzheimer's Disease Drug Revenue and Growth Rate (2011-2021)
Table United States Alzheimer's Disease Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Alzheimer's Disease Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Alzheimer's Disease Drug Sales Share by Manufacturers
Figure 2016 Alzheimer's Disease Drug Sales Share by Manufacturers
Table United States Alzheimer's Disease Drug Revenue by Manufacturers (2015 and 2016)
Table United States Alzheimer's Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Alzheimer's Disease Drug Revenue Share by Manufacturers
Table 2016 United States Alzheimer's Disease Drug Revenue Share by Manufacturers
Table United States Market Alzheimer's Disease Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Alzheimer's Disease Drug Average Price of Key Manufacturers in 2015
Figure Alzheimer's Disease Drug Market Share of Top 3 Manufacturers
Figure Alzheimer's Disease Drug Market Share of Top 5 Manufacturers
Table United States Alzheimer's Disease Drug Sales by Type (2011-2016)
Table United States Alzheimer's Disease Drug Sales Share by Type (2011-2016)
Figure United States Alzheimer's Disease Drug Sales Market Share by Type in 2015
Table United States Alzheimer's Disease Drug Revenue and Market Share by Type (2011-2016)
Table United States Alzheimer's Disease Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Alzheimer's Disease Drug by Type (2011-2016)
Table United States Alzheimer's Disease Drug Price by Type (2011-2016)
Figure United States Alzheimer's Disease Drug Sales Growth Rate by Type (2011-2016)
Table United States Alzheimer's Disease Drug Sales by Application (2011-2016)
Table United States Alzheimer's Disease Drug Sales Market Share by Application (2011-2016)
Figure United States Alzheimer's Disease Drug Sales Market Share by Application in 2015
Table United States Alzheimer's Disease Drug Sales Growth Rate by Application (2011-2016)
Figure United States Alzheimer's Disease Drug Sales Growth Rate by Application (2011-2016)
Table Eisai Basic Information List
Table Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eisai Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table Janssen Basic Information List
Table Janssen Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table Forest Laboratories Basic Information List
Table Forest Laboratories Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Forest Laboratories Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table H. Lundbeck Basic Information List
Table H. Lundbeck Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table H. Lundbeck Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table Merz Basic Information List
Table Merz Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merz Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Alzheimer's Disease Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer's Disease Drug
Figure Manufacturing Process Analysis of Alzheimer's Disease Drug
Figure Alzheimer's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer's Disease Drug Major Manufacturers in 2015
Table Major Buyers of Alzheimer's Disease Drug
Table Distributors/Traders List
Figure United States Alzheimer's Disease Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Alzheimer's Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Alzheimer's Disease Drug Production Forecast by Type (2016-2021)
Table United States Alzheimer's Disease Drug Consumption Forecast by Application (2016-2021)